Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis

Autor: Carla Colombo, Jessie M. Hulst, E. Van der Wiel, Carmen Ribes-Koninckx, R. Nobili, Celeste Barreto, I. Asseiceira, Anna Bulfamante, Joaquim Calvo-Lerma, Luísa Pereira, J.G. Mainz, Mieke Boon, B.A.M. van Schijndel, Etna Masip, Victoria Fornés, María Garriga, P. Crespo, M. Ruperto, K. De Boeck, Hettie M. Janssens, Peter Witters, I. Claes, Trudy Havermans, Saioa Vicente

Publikováno v: Journal of Cystic Fibrosis, 19(4), 562-568. Elsevier
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Background: Most patients with cystic fibrosis (CF) suffer from pancreatic insufficiency (PI), leading to fat malabsorption, malnutrition, abdominal discomfort and impaired growth. Pancreatic enzyme replacement therapy (PERT) is effective, but eviden

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94106794aa0d92a677112abe2a63b688
https://pure.eur.nl/en/publications/af11e923-bc32-4b67-a9df-2f1cc8e918c5